| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Benzeneacetamide, N-[3-[(3,4-dihydro-2,4-dioxo-3-propylthieno[3,2-d]pyrimidin-1(2H)-yl)methyl]phenyl]- |
N-(3-((2,4-DIOXO-3-PROPYL-3,4-DIHYDROTHIENO[3,2-D]PYRIMIDIN-1(2H)-YL)METHYL)PHENYL)-2-PHENYLACETAMID |
2098776-03-3 |
詳細(xì)
|
| N-OMEGA-HYDROXYL-NOR-L-ARGININE, DIHYDROCHLORIDE |
NΩ-羥基或- L -精氨酸鹽酸鹽 |
291758-32-2 |
詳細(xì)
|
| N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea |
N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea |
97627-24-2 |
詳細(xì)
|
| (S)-2-Amino-N1-benzhydrylpentanediamide |
(S)-2-氨基-N1-苯并二胺 |
2429878-52-2 |
詳細(xì)
|
| Benzeneacetonitrile, 4-cyano-α-[[4-[[2-(dimethylamino)ethyl]methylamino]phenyl]methylene]- |
Benzeneacetonitrile, 4-cyano-α-[[4-[[2-(dimethylamino)ethyl]methylamino]phenyl]methylene]- |
2530161-67-0 |
詳細(xì)
|
| 1-Pentanone, 1-(1,3,4,9-tetrahydro-1-phenyl-2H-pyrido[3,4-b]indol-2-yl)- |
2,3,4,9-四氫-2-(1-氧代戊基)-1-苯基-1H-吡啶并[3,4-b]吲哚 |
334939-35-4 |
詳細(xì)
|
| (4-(4-methoxyphenyl)piperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone |
(4-(4-甲氧基苯基)哌嗪-1-基)(2-(4-甲基哌啶-1-基)苯并[d]噻唑-6-基)甲酮 |
906258-69-3 |
詳細(xì)
|
| RBPJ Inhibitor-1(RIN1) |
|
|
詳細(xì)
|
| KB3022 |
帕米甘草 |
101001-34-7 |
詳細(xì)
|
| 2-(3,4-Dihydroxy-benzylidene)-benzofuran-3-one, Sphingosine Kinase Inhibitor V |
2-(3,4-二羥基亞芐基)苯并呋喃-3(2H)-酮 |
24418-86-8 |
詳細(xì)
|
| Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) |
利巴韋林羧基酸/利巴韋林雜質(zhì)A |
39925-19-4 |
詳細(xì)
|
| 2-Chloro-N-[(9H-fluoren-9-ylamino)carbonyl]-6-fluorobenzamide |
2-氯-N-[(9H-芴-9-氨基)羰基]-6-氟苯甲酰胺 |
1186372-20-2 |
詳細(xì)
|
| MYCMI-6 |
MYCMI-6 |
681282-09-7 |
詳細(xì)
|
| ML-180 |
ML-180 |
863588-32-3 |
詳細(xì)
|
| Apcin |
Apcin |
300815-04-7 |
詳細(xì)
|
| STAT3-IN-1 |
STAT3-IN-1 |
2059952-75-7 |
詳細(xì)
|
| N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE HYDROCHLORIDE |
N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE HYDROCHLORIDE |
40616-75-9 |
詳細(xì)
|
| A 1120 |
A-1120 |
1152782-19-8 |
詳細(xì)
|
| CLONIDINE RELATED COMPOUND A (25 MG) (ACET-YLCLONIDINE) |
可樂定雜質(zhì)A |
54707-71-0 |
詳細(xì)
|
| CYCLIZINE HCL |
苯甲嗪 |
82-92-8 |
詳細(xì)
|
| Tryptophan, N-indol-3-ylacetyl- (6CI) |
N-(3-吲哚乙?；?-L-色氨酸 |
57105-53-0 |
詳細(xì)
|
| Parimifasor |
PARIMIFASOR |
1796641-10-5 |
詳細(xì)
|
| (4-benzylpiperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone |
(4-芐基哌嗪-1-基)(2-(4-甲基哌啶-1-基)苯并[d]噻唑-6-基)甲酮 |
906258-48-8 |
詳細(xì)
|
| 10-methyl-9-(phenoxycarbonyl) Acridinium (trifluoromethylsulfonate) |
9-[(苯氧基)羰基]-10甲基三氟甲酰胺磺酸鹽 |
161006-14-0 |
詳細(xì)
|
| (S)-(+)-2-METHYLBUTYL P-[(P-METHOXYBENZYLIDENE)AMINO]CINNAMATE |
(S)-2-甲基丁基3-(4-((4-甲氧基亞芐基)氨基)苯基)丙烯酸酯 |
24140-30-5 |
詳細(xì)
|
| Benzonitrile, 3-[[(1S,2S,3R)-2,3-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluoro- |
PT2977 |
1672668-24-4 |
詳細(xì)
|
| N'-((6-Methylpyridin-2-yl)methylene)pyrrolidine-1-carbothiohydrazide |
N'-((6-甲基吡啶-2-基)亞甲基)吡咯烷-1-硫代肼 |
907549-72-8 |
詳細(xì)
|
| 1H-Benzotriazole-7-carboxylic acid, 1-methyl-5-(2'-methyl[1,1'-biphenyl]-4-yl)- |
AG-636 |
1623416-31-8 |
詳細(xì)
|
| 2-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)-2-DEOXYGLUCOSE |
2-(N-7-硝基-2,1,3-苯并惡二唑-4-氨基)-2-脫氧-D-葡萄糖 |
186689-07-6 |
詳細(xì)
|
| N,N-diethyl-2-((6-methylpyridin-2-yl)methylene)hydrazinecarbothioamide |
N,N-二乙基-2-((6-甲基吡啶-2-基)亞甲基)肼基硫酰胺 |
210700-64-4 |
詳細(xì)
|
| 3-N-BUTYLPHTHALIDE |
丁苯酞 |
6066-49-5 |
詳細(xì)
|
| GSK778 |
GSK778 |
2451862-42-1 |
詳細(xì)
|
| (R)-N- (4-(chlorodifluoromethoxy)phenyl)- 6-(3- hydroxypyrrolidin-1- yl)-5- (1H-pyrazol- 5-yl)nicotinamide |
ABL-001 |
1492952-76-7 |
詳細(xì)
|
| CC-90009 |
CC-90009 |
1860875-51-9 |
詳細(xì)
|
| (1R,2R)-2-fluorocyclopropanecarboxylic acid |
(1R,2R)-2-氟環(huán)丙烷羧酸 |
127199-13-7 |
詳細(xì)
|
| KX2-391 |
5-[4-[2-(4-嗎啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺 |
897016-82-9 |
詳細(xì)
|
| Paquinimod |
帕奎莫德 |
248282-01-1 |
詳細(xì)
|
| BI 2536 |
BI 2536 |
755038-02-9 |
詳細(xì)
|
| CC-885 |
CC885 |
1010100-07-8 |
詳細(xì)
|
| 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine |
AT-56 |
162640-98-4 |
詳細(xì)
|
| ALW-II-41-27 |
ALW-II-41-27 |
1186206-79-0 |
詳細(xì)
|
| CDKI-73 |
CS-2259 |
1421693-22-2 |
詳細(xì)
|
| MYF-01-37 |
MYF-01-37 |
2416417-65-5 |
詳細(xì)
|
| BETd-260 |
BETd-260 |
2093388-62-4 |
詳細(xì)
|
| LMK-235 |
N-[[6-(羥基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺 |
1418033-25-6 |
詳細(xì)
|
| STM2457 |
STM2457 |
2499663-01-1 |
詳細(xì)
|
| BDTX-189 |
BDTX-189 |
2414572-47-5 |
詳細(xì)
|
| MLI-2 |
REL-3-[6-[(2R,6S)-2,6-二甲基-4-嗎啉基]-4-嘧啶基]-5-[(1-甲基環(huán)丙基)氧基]-1H-吲唑 |
1627091-47-7 |
詳細(xì)
|
| Parsaclisib |
化合物PARSACLISIB |
1426698-88-5 |
詳細(xì)
|
| N-(1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)-1-(3-fluorobenzyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxamide |
N-(1,2-二甲基-1H-苯并咪唑-5-基)-1-[(3-氟苯基)甲基]-1H-吡咯[3,2-c]吡啶-2-羧酰胺 |
920978-76-3 |
詳細(xì)
|
| Ethanone, 2-chloro-1-(3-indolyl)- |
2-氯-1-(1H-吲哚-3-基)-乙酮 |
28755-03-5 |
詳細(xì)
|
| 1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1357349-91-7 |
詳細(xì)
|
| N-0437 |
5,6,7,8-四氫-6- [丙基[2-（2-噻吩基）乙基]氨基]-1-萘酚 |
92206-54-7 |
詳細(xì)
|
| 2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]- |
5-(5-(6-(4-乙?；哙?1-基)-3-硝基吡啶-2-基)-2-氟亞芐基)噻唑烷-2,4-二酮 |
853953-65-8 |
詳細(xì)
|
| 1-METHYL-4-[THIOXANTHEN-9-YLIDENE]PIPERIDINE MALEATE SALT |
馬來酸甲哌硫蒽 |
13187-06-9 |
詳細(xì)
|
| MP07-66 |
MP07-66 |
1938056-90-6 |
詳細(xì)
|
| CHR 6494 trifluoroacetate |
CHR 6494 trifluoroacetate |
1458630-17-5 |
詳細(xì)
|
| N-[4-(2-BROMO-4,5-DIFLUOROPHENOXY)PHENYL]-L-ASPARAGINE |
N-[4-(2-溴-4,5-二氟苯氧基)苯基]-L-天冬酰胺 |
868359-05-1 |
詳細(xì)
|
| 1-(3-Nitrophenyl)-3-(4-pyridinylmethyl)-pyrido[2,3-d]pyrimidine-2,3-(1H,3H)-dionehydrochloride |
化合物RS-25344 |
152814-89-6 |
詳細(xì)
|
| 2-Pyridinamine, 5,6-bis(4-methoxy-3-methylphenyl)- |
化合物WSB1 DEGRADER 1 |
2306039-66-5 |
詳細(xì)
|
| (E)-(5-nitrofuran-2-yl)methylideneamino]urea |
(E)-2-((5-硝基呋喃-2-基)亞甲基)肼甲酰胺 |
112574-44-4 |
詳細(xì)
|
| NS3861 >=98% (HPLC) |
化合物NS3861 |
216853-59-7 |
詳細(xì)
|
| EGFR-IN-5 |
EGFR-IN-5 |
2225887-26-1 |
詳細(xì)
|
| 3-(3-Bromo-2-thienyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene fumarate |
化合物3-(3-BROMO-2-THIENYL)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-2-ENE FUMARATE |
216853-60-0 |
詳細(xì)
|
| ARP 100 |
ARP100 |
704888-90-4 |
詳細(xì)
|
| 5-(3-(1-naphthoyl)-1H-indol-1-yl)pentanenitrile |
AM-2232 |
335161-19-8 |
詳細(xì)
|
| CHR-6494 |
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-B]噠嗪-6-胺 |
1333377-65-3 |
詳細(xì)
|
| AC710 |
N-[4-[[[[5-(叔丁基)-3-異惡唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺 |
1351522-04-7 |
詳細(xì)
|
| 4-KETO ALL-TRANS-RETINOIC ACID METHYL ESTER |
4-KETO ALL-TRANS-RETINOIC ACID METHYL ESTER |
38030-58-9 |
詳細(xì)
|
| Butamirate Impurity 1 |
N,N-二乙基-2-苯基丁酰胺 |
92321-53-4 |
詳細(xì)
|
| KI-7 |
KI-7 |
1489263-00-4 |
詳細(xì)
|
| 4-Pyrimidinamine, N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-(4-morpholinyl)- |
化合物RIMTUZALCAP |
2167246-24-2 |
詳細(xì)
|
| Oxiconazole nitrate |
硝酸奧昔康唑 |
64211-46-7 |
詳細(xì)
|
| RS 25344 hydrochloride |
1-(3-硝基苯基)-3-(吡啶-4-基甲基)吡啶并[2,3-D]嘧啶-2,4(1H,3H)-二酮鹽酸鹽 |
152815-28-6 |
詳細(xì)
|
| Benzamide, N-hydroxy-4-[[[[(2-methoxyphenyl)amino]carbonyl]amino]methyl]- |
N-羥基-4-((3-(2-甲氧基苯基)脲基)甲基)苯甲酰胺 |
1454902-97-6 |
詳細(xì)
|
| 2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime |
2-甲基-5-(1-甲基乙基)-2,5-環(huán)己二烯-1,4-二酮 1-[O-(2-甲基苯甲酰)肟] |
321688-88-4 |
詳細(xì)
|
| 4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
2314467-59-7 |
詳細(xì)
|
| TH1020 |
TH1020 |
1841460-82-9 |
詳細(xì)
|
| N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide |
CS-2774 |
942206-85-1 |
詳細(xì)
|
| N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide) |
N,N'-[磺?；?4,1-亞苯基)]二(2-氯乙酰胺) |
17328-16-4 |
詳細(xì)
|
| MF-438 |
MF 438 |
921605-87-0 |
詳細(xì)
|
| EG1 (Pax2 inhibitor EG1) |
2-(4-(2-甲氧基苯甲酰氨基)苯甲酰氨基)苯甲酸 |
693241-54-2 |
詳細(xì)
|
| MIT 9952-53 |
MIT 9952-53 |
321673-30-7 |
詳細(xì)
|
| GS143 |
4-(3-芐基-4-((5-(2-氟苯基)呋喃-2-基)亞甲基)-5-氧代-4,5-二氫-1H-吡唑-1-基)苯甲酸 |
916232-21-8 |
詳細(xì)
|
| MBX2329 |
1-(2-(2-乙基苯氧基)乙基)氮雜環(huán)庚烷鹽酸鹽 |
1438272-42-4 |
詳細(xì)
|
| Verubulin |
(4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺 |
827031-83-4 |
詳細(xì)
|
| GOT1 inhibitor 2c |
N-(4-氯苯基)-4-(1H-吲哚-4-基)哌嗪-1-甲酰胺 |
732973-87-4 |
詳細(xì)
|
| 2-(4-fluorophenyl)-3-(isopropyl(methyl)amino)quinoxaline-6-carboxylic acid |
BIOE-1115 |
1268863-35-9 |
詳細(xì)
|
| KM91104 |
KM 91104 |
304481-60-5 |
詳細(xì)
|
| Cadralazine |
卡屈嗪 |
64241-34-5 |
詳細(xì)
|
| 2-methyl-5-nitroimidazol-1-ylacetic acid |
甲硝唑雜質(zhì)G |
1010-93-1 |
詳細(xì)
|
| Bis(trans-cinnamic acid)anhydride |
反式-桂皮酸酐 |
21947-71-7 |
詳細(xì)
|
| ZL006 |
化合物ZL006 |
1181226-02-7 |
詳細(xì)
|
| TMEM16AInhibitorsRevealTMEM16A(T16Ainh-A01) |
T16AINH-A01 |
552309-42-9 |
詳細(xì)
|
| 1-(5-Chloro-2-hydroxyphenyl)-ethanone 2-(2,4,6-trichlorophenyl)hydrazone |
1-(5-Chloro-2-hydroxyphenyl)-ethanone 2-(2,4,6-trichlorophenyl)hydrazone |
219315-22-7 |
詳細(xì)
|
| 1,6-dimethyl-3-phenylpyrimido[5,4-e][1,2,4]triazine-5,7-dione |
化合物3-PHENYLTOXOFLAVIN |
32502-63-9 |
詳細(xì)
|
| Metronidazole-Impurity-11 |
米那普侖雜質(zhì) |
1410831-12-7 |
詳細(xì)
|
| PQR-530 |
PQR530 |
1927857-61-1 |
詳細(xì)
|
| TOCAINIDE |
妥卡尼 |
41708-72-9 |
詳細(xì)
|
| N2,N4-bis(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine |
化合物 AZA1 |
1071098-42-4 |
詳細(xì)
|